생화학 시약 시장 : 제품 유형, 용도 및 최종 용도별 - 세계 예측(2024-2032)

Global Biochemical Reagents Market will infer over 8.5% CAGR from 2024 to 2032, driven by the growing shift toward personalized medicine. As healthcare moves toward tailored treatments based on individual genetic profiles, there is a heightened demand for biochemical reagents used in genetic testing and molecular diagnostics. These reagents play a crucial role in identifying genetic variations and biomarkers that influence disease susceptibility and treatment response.

Against this backdrop, in July 2024, Wisconsins Biohealth Tech Hub secures USD 49 million in federal funding to advance precision medicine. The investment aims to boost innovation, production capabilities, and workforce development within the personalized medicine sector.

This trend reflects a broader emphasis on precision healthcare, where accurate and specific biochemical assays are essential for developing targeted therapies and improving patient outcomes, thriving the market forward in research, diagnostics, and therapeutic applications.

The overall biochemical reagents market is categorized based on product type, application, end-use, and region.

The genomics segment will exhibit a remarkable CAGR during 2024-2032. The genomics segment will experience an upsurge due to advancements in genomic research and personalized medicine. These reagents are essential in genomics for tasks such as DNA sequencing, PCR amplification, and gene expression analysis. With increasing applications in understanding genetic variations, disease mechanisms, and therapeutic targets, biochemical reagents enable precise and efficient genomic analysis. This capability supports the development of personalized therapies tailored to individual genetic profiles, augmenting the demand for high-quality reagents that ensure accuracy and reliability in genomic studies and clinical diagnostics.

The cell and tissue culture segment will garner a promising biochemical reagents market share by 2032. The demand for biochemical reagents is growing in the cell and tissue culture segment primarily due to advancements in biotechnology and pharmaceutical research. These reagents play a crucial role in maintaining cell viability, growth, and differentiation in controlled laboratory environments. With increasing applications in drug development, regenerative medicine, and bio-processing, biochemical reagents facilitate the cultivation and manipulation of cells and tissues for various research and therapeutic purposes. Their role in ensuring reproducibility and reliability in cell-based assays and experiments underscores their importance in advancing biomedical sciences and meeting the evolving needs of bio pharmaceutical industries.

Europe biochemical reagents market will grow at an impressive CAGR during the period from 2024 to 2032. The demand for biochemical reagents is experiencing growth in Europe, driven by robust investments in biotechnology and healthcare infrastructure. Europe focus on research and development in bio-pharmaceuticals and personalized medicine is amplifying the need for advanced biochemical reagents. Additionally, stringent regulatory frameworks that ensure high standards of research and diagnostics are fostering a favorable environment for biochemical reagents industry expansion. The increasing prevalence of chronic diseases and aging populations also contribute to heightened demand, as biochemical reagents play a critical role in disease diagnosis, treatment monitoring, and therapeutic development.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing R&D activities in life sciences and biotechnology
    • 3.2.1.2 Rising incidence of chronic and infectious diseases
    • 3.2.1.3 Technological advancements in biochemical research
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of biochemical reagents
    • 3.2.2.2 Stringent regulatory policies and quality control standards
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Polymerase chain reaction reagent kits
• 5.3 Cell and tissue culture reagents
• 5.4 Electrophoresis reagents
• 5.5 Chromatography reagents
• 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 KEY trends
• 6.2 Drug discovery and development
• 6.3 Genomics
• 6.4 Proteomics
• 6.5 Diagnostics
• 6.6 Biotechnology research
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Biotechnology & pharmaceutical companies
• 7.3 Academic and research institutes
• 7.4 Hospitals and diagnostic laboratories
• 7.5 Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs)

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Agilent Technologies Inc.
• 9.3 Becton, Dickinson and Company
• 9.4 Bio-Rad Laboratories, Inc.
• 9.5 Merck KGaA
• 9.6 F. Hoffmann-La Roche Ltd.
• 9.7 Johnson and Johnson
• 9.8 Siemens Healthineers AG
• 9.9 Thermo Fisher Scientific Inc.
• 9.10 Waters Corporation